Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals

North America, California, United States, San Diego

Description

Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.

Investor Profile

Crinetics Pharmaceuticals has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Crinetics Pharmaceuticals frequently co-invest with?

GordonMD Global Investments
North America, California, United States, Beverly Hills
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Frazier Life Sciences
North America, California, United States, Menlo Park
Co-Investments: 2
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Crinetics Pharmaceuticals?

Radionetics Oncology

California City, California, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Health CareMedicalOncologyPharmaceuticalTherapeutics
Series AJan 3, 2024
Amount Raised: $52,500,000
Radionetics Oncology

California City, California, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Health CareMedicalOncologyPharmaceuticalTherapeutics
Series AAug 14, 2023
Amount Raised: $52,500,000